Gu, Ye
He, Qiaoxian
Xie, Lu
Chen, Fangfang
Jin, Hangbin
Lou, Lilan
Zhang, Xiaofeng
Funding for this research was provided by:
National Natural Science Foundation of China (No.82001696)
Science and Technology Project of Hangzhou Health Commission (A20200119)
Hangzhou Medical and Health Science and Technology Plan (No. A20230021)
Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province (2020E10021)
Zhejiang Medical and Health Science and Technology Plan (No. WKJ-ZJ-2136 2020KY703, 2021KY848, 2021437779, 2022RC056, 2023RC229 and 2025KY1062)
The Construction Fund of Key Medical Disciplines of Hangzhou (OO20190001)
Key R&D Program of Zhejiang Province (No.2023C03054 and No.2024C03048)
Natural Science Foundation of Zhejiang Province (No.LQN25H030007)
Article History
Received: 2 September 2024
Accepted: 21 January 2025
First Online: 4 April 2025
Declarations
:
: The authors declare no competing interests.